Top 50 Medical Device Startup Investors in Belgium (August 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Capricorn Partners
VC Fund
|
6 | Belgium, The Netherlands, United States | Series A, Series B | Biotechnology, Health Care, Software | $3.3M–$42M |
|
PMV
VC Fund
|
6 | Belgium, United States, The Netherlands | Seed, Series A, Series B | Software, Biotechnology, Health Care | $1M–$42M |
|
Meusinvest (Noshaq)
VC Fund
|
5 | Belgium, France, Germany | Series A, Seed, Series B | Biotechnology, Health Care, Medical | $137k–$31M |
|
S.R.I.W.
VC Fund
|
5 | Belgium, United States, Spain | Series A, Series B | Health Care, Biotechnology, Manufacturing | $411k–$75M |
|
White Fund
VC Fund
|
5 | Belgium, United States | Seed, Series A, Venture - Series Unknown | Health Care, Medical, Medical Device | $4.1M–$12M |
|
Pierre Rigaux
Angel
|
4 | Belgium | Seed, Pre-Seed, Convertible Note | Sports, Medical Device | $556k–$1.2M |
|
imec.istart Future Fund
VC Fund
|
3 | Belgium, United Kingdom | Seed, Pre-Seed, Series A | Health Care, Medical Device, Satellite Communication | $1.2M–$5.7M |
|
Vives Louvain Technology Fund
VC Fund
|
3 | Belgium, France, United States | Series A, Series B, Seed | Health Care, Biotechnology, Medical | $491k–$125M |
|
Namur Invest
VC Fund
|
3 | Belgium, United States | Series A, Seed | Health Care, Medical Device, Auctions | $658k–$18M |
|
WING by Digital Wallonia
VC Fund
|
3 | Belgium | Seed, Series A, Convertible Note | Software, Health Care, Information Technology | $219k–$11M |
|
Newton Biocapital
VC Fund
|
3 | Belgium, Japan, France | Series A, Seed | Biotechnology, Medical, Health Care | $2.7M–$84M |
|
Kurma Partners
VC Fund
|
2 | France, Switzerland, Spain | Series A, Seed, Series B | Health Care, Biotechnology, Medical | $2.7M–$98M |
|
Sensinnovat
VC Fund
|
2 | Belgium, France | Seed, Series A, Series B | Health Care, Manufacturing, Medical Device | $5.2M–$17M |
|
Amazon Alexa Fund
VC Fund
|
2 | United States, United Kingdom, Canada | Seed, Series A, Series B | Software, Artificial Intelligence, Machine Learning | $120k–$120M |
|
Spreds
VC Fund
|
2 | Belgium, France | Series A, Seed, Pre-Seed | Information Technology, E-Commerce, Health Care | $150k–$2.5M |
|
Sambrinvest
VC Fund
|
2 | Belgium, France, Spain | Seed, Series A, Series B | Biotechnology, Health Care, Medical | $544k–$46M |
|
TCD Capital
VC Fund
|
2 | Belgium, France | Series A, Series B, Venture - Series Unknown | Biotechnology, Health Care, Medical Device | $2.1M–$18M |
|
UI Investissement
VC Fund
|
2 | France, Spain, Canada | Private Equity, Seed, Series A | Manufacturing, Software, Health Care | $1.5M–$49M |
|
Inventures SA
VC Fund
|
2 | Belgium, France, United Kingdom | Series A, Seed | Health Care, Biotechnology, Manufacturing | $82k–$14M |
|
Pierre-Yves Muller
Angel
|
2 | Belgium | Seed, Pre-Seed | Sports, Medical Device | |
|
GoBeyond
VC Fund
|
2 | Switzerland, Germany, United Kingdom | Seed, Series A | Information Technology, Medical, Software | $544k–$10M |
|
imec.xpand
VC Fund
|
2 | Belgium, United States, Germany | Seed, Series A, Series B | Semiconductor, Manufacturing, Medical Device | $3.3M–$100M |
|
Carevolution
VC Fund
|
2 | Belgium, United States | Seed | Health Care, Medical Device, Medical | $1.1M–$4.5M |
|
CAREvolution
VC Fund
|
2 | Belgium | Seed, Venture - Series Unknown | Health Care, Medical Device, GovTech | $1.2M–$4.5M |
|
Spinventure
VC Fund
|
2 | Belgium | Series A | Health Care, Biotechnology, Medical | $768k–$15M |
|
Yves Beudin
Angel
|
1 | Belgium | Angel | Medical, Health Care, Biotechnology | |
|
SHIGERU AG
VC Fund
|
1 | United States, Japan, Belgium | Pre-Seed, Seed, Series A | Blockchain, Cloud Computing, Virtual Reality | $1M–$3M |
|
New Rhein
VC Fund
|
1 | United States, Israel, Belgium | Series A, Series B, Series C | Medical, Biotechnology, Health Care | $7M–$197M |
|
Manuardeo
VC Fund
|
1 | Belgium | Series A, Series B | Medical, Diabetes, Health Care | |
|
Jean Dessain
Angel
|
1 | Belgium | Angel | Medical, Health Care, Biotechnology | |
|
SoFi
VC Fund
|
1 | Belgium, United States, Brazil | Series A, Seed | Software, FinTech, Apps | $500k–$25M |
|
Invest Mons Borinage Centre
VC Fund
|
1 | Belgium | Seed, Pre-Seed | Agriculture, AgTech, Farming | |
|
Invest BW
VC Fund
|
1 | Belgium, Germany | Series A, Seed, Grant | Health Care, AgTech, Medical | $1.1M–$18M |
|
Pierre Drion
Angel
|
1 | Belgium | Series A, Series B | Biotechnology, Health Care, Life Science | $8.8M–$26M |
|
Flanders Future Techfund
VC Fund
|
1 | Belgium, The Netherlands | Seed, Series A | Medical, Biotechnology, Clinical Trials | $2.7M–$33M |
|
Fidimec
VC Fund
|
1 | Belgium | Seed, Series A | Industrial, Semiconductor, Medical | $2.2M–$7.7M |
|
Nina Capital
VC Fund
|
1 | United States, United Kingdom, Germany | Seed, Pre-Seed, Series A | Health Care, Artificial Intelligence, Software | $529k–$21M |
|
Karista
VC Fund
|
1 | France, United States, Finland | Seed, Series A, Series B | Software, Biotechnology, Health Care | $713k–$33M |
|
Parana Management
VC Fund
|
1 | Belgium | Series A, Series B | Medical, Diabetes, Health Care | |
|
EQT Life Sciences
VC Fund
|
1 | United States, The Netherlands, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $7.3M–$165M |
|
LeanSquare
VC Fund
|
1 | Belgium, France, United States | Seed, Series A | Software, Music, Information Technology | $200k–$12M |
|
Eduardo Ronzano
Angel
|
1 | France, United States, United Kingdom | Seed, Pre-Seed, Angel | Software, E-Commerce, SaaS | $150k–$5.5M |
|
Boehringer Ingelheim Venture Fund
VC Fund
|
1 | United States, Germany, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $1.8M–$50M |
|
Qbic
VC Fund
|
1 | Belgium | Seed, Series B | Health Care, Biotechnology, AgTech | $3.7M–$12M |
|
Omega Funds
VC Fund
|
1 | United States, Switzerland, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $14M–$208M |
|
Fonds Vives II (University of Louvain, UCL)
VC Fund
|
1 | Belgium, United States | Series A, Series B, Seed | Biotechnology, Health Care, Medical | $6.6M–$75M |
|
Sofinex
VC Fund
|
1 | Belgium | Series A | Wellness, Lifestyle, Health Care | |
|
Delta Partners
VC Fund
|
1 | Ireland, United States, United Kingdom | Seed, Series A | Software, Information Technology, Health Care | $795k–$6.6M |
|
SFPI-FPIM
VC Fund
|
1 | Belgium, United States, The Netherlands | Series B, Series A | Health Care, Biotechnology, Medical | $4.3M–$75M |
|
Earlybird Venture Capital
VC Fund
|
1 | Germany, United States, United Kingdom | Series A, Seed, Series B | Software, Information Technology, Artificial Intelligence | $1.5M–$75M |
| Access all 146 investors in Belgium Medical Device startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Capricorn Partners is a unique independent manager of venture capital, growth capital and quoted equity funds
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Series A, Series B
- Geography: Belgium, The Netherlands, United States
Investor stats
- Total investments: 120
- Round size: Series A $3.3M–$18M; Series B $5.3M–$42M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Sensolus — Sensolus provides care-free tracking of your valuable non-powered assets directly from the cloud.Sensolus offers turnkey solutions for wireless, low-power context-aware sensing. Sensolus developed a personal product line of low-power tracker systems called STICKNTRACK.Sensolus is built upon many years of expertise in low-power networks,wireless sensor design, cloud-based sensor management, analytics, and applications.
- Endo Tools Therapeutics — Endo Tools Therapeutics is dedicated to the development of innovative devices that provide therapeutic interventions for gastric conditions
- Delft Advanced Biorenewables — We enable the bio-economy by improving the productivity of fermentations with our in-situ product recovery (ISPR) technology.
Do and dare company
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Series A, Series B
- Geography: Belgium, United States, The Netherlands
Investor stats
- Total investments: 156
- Round size: Seed $1M–$3.8M; Series A $2.7M–$40M; Series B $6.6M–$42M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- Biotalys — Biotalys is an Agricultural Technology (AgTech) company that employs its proprietary Agrobody technology platform to develop crop and food protection products. The company develops a new generation of protein-based biocontrol solutions, shaping the future of sustainable and safe food supply. Biotalys' unique protein-based biocontrols combinethe high-performance characteristics of chemicals with the clean safety profile of biologicals, making them ideal crop protection agents for both pre- and post-harvest applications.It was incorporated in 2013 and is based in the Biotech hub in Ghent, Belgium.
- Borro — Cashless deposit system
- Storm — Storm is een producent van hernieuwbare energie. Samen met ons team ontwikkelen, bouwen en exploiteren we duurzame energieprojecten over het hele land: van wind- en zonneparken tot snellaadstations en batterijopslag. Dit telkens tegen een zo laag mogelijke maatschappelijke kost.
Noshaq offers financial services to help businesses develop.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed, Series B
- Geography: Belgium, France, Germany
Investor stats
- Total investments: 78
- Round size: Seed $137k–$6M; Series A $3.6M–$16M; Series B $680k–$31M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- TrustUp — TrustUp is the home contractors platform, connects homeowners with verified quality home improvement.
- Le Fourgon — Le Fourgon provides contained drinks for home delivery. They offer milk, water, beer, wine, fruit juice, and sodas. They allow customers to have their drinks delivered free of charge during the day.
- Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
The S.R.I.W. Group is an institution at the heart of the financial market that assists entrepreneurs in creating and developing businesses in the Walloon region. It reflects the effort of Wallonian industry in facing the challenges of the creation of economic value in the 21st century. Since its creation in 1979, the Société Régionaled’Investissement de Wallonie has continuously been expanding its abilities to adapt and anticipate as well as its flexibility in order to meet the requirements of its partners who are confronted with the evolution of the world economy. The principles of good governance, a strong business culture and shared values at the heart of the Group constitute important assets to capture the changing realities of the market and progress in a sustainable development perspective.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Manufacturing
- Stage:Series A, Series B
- Geography: Belgium, United States, Spain
Investor stats
- Total investments: 111
- Round size: Series A $411k–$31M; Series B $1.6M–$75M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Univercells — Mix parlay, atau lebih dikenal sebagai parlay bola atau hanya parlay, merupakan taruhan judi bola online yang menggabungkan minimal 2 hingga 10 tim pertandingan sepak bola menjadi 1 tiket taruhan.
- Intressa Vascular — Intressa Vascular provides innovative solutions to address life-threatening cardiovascular conditions such as aortic dissection.
- Santero Therapeutics — This is the homepage of the website
For game changers in medtech
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Belgium, United States
Investor stats
- Total investments: 12
- Round size: Seed $4.1M–$11M; Series A $5.3M–$12M; Venture - Series Unknown $5.5M–$11M
- Lead/follow: 67% lead, 33% follow
- Last fund: May invest from a new fund soon — raised $23M in 2019
Portfolio highlights
- neuroClues — An easy-to-use eye-tracking environment to help practitioners instantaneously quantify their clinical exam
- Minze Health — Minze Health is a health tech start-up that builds creative digital health solutions for urology, pelvic health, and (in)continence care.
- Clouds of care — Increasing your probability of success through the adoption of meaningful endpoints, starting from electrophysiology.
Pierre Rigaux
Show more...Investment focus
- Industry: Sports, Medical Device
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: Belgium
Investor stats
- Total investments: 4
- Round size: Seed $556k–$1.2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MYOCENE — Myocene is a Liège-based sports technology company which creates unique and innovative devices for measuring muscle fatigue and performance.
Early-stage venture capital fund focused on alumni of the imec.istart accelerator and exceptional tech founders building in Applied AI, Spacetech, Healthtech, and Deep Tech. Based in Antwerp, Belgium.
Show more...Investment focus
- Industry: Health Care, Medical Device, Satellite Communication
- Stage:Seed, Pre-Seed, Series A
- Geography: Belgium, United Kingdom
Investor stats
- Total investments: 10
- Round size: Seed $1.2M–$5.7M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- EDGX — EDGX, founded in 2023 in Ghent, is a Belgian Space Tech company developing high-speed edge computing units for satellites. Its NVIDIA-powered Sterna Computer and SpaceFeather software enable real-time, AI-driven on-orbit data processing for applications in communication, Earth observation, and intelligence.
- nxgsat — We build interoperable satellite networks.
- OnTracx — OnTracx measures and manages the load your body experiences, step by step. Our sensor captures real-time load during any run, bringing lab-level precision to real-world conditions. The app empowers runners to monitor their progress, while OnTracx Pro gives professionals the tools for load screenings, training program creation, and effortless athlete follow-up.
Vives is an interregional seed and early stage technology multi-sector fund. The new fund, initiated by UCLouvain, is a unique European inter-university fund having access to world class innovations from leading EU top universities.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Seed
- Geography: Belgium, France, United States
Investor stats
- Total investments: 27
- Round size: Seed $1.6M–$7.3M; Series A $491k–$46M; Series B $4.7M–$125M
- Lead/follow: 4% lead, 96% follow
- Last fund: May invest from a new fund soon — raised $37M in 2020
Portfolio highlights
- BOTALYS — BOTALYS uses an innovative Biomimetic Indoor Farming technology to recreate the ideal wild conditions for rare botanicals to grow in. We develop pristine & potent botanical ingredients for the Nutraceutical and Cosmetic industries.
- Sunrise — Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate asin-lab sleep studies, at a fraction of the cost.Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.
- Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
Namur Invest Group provides companies with financing solutions in various forms adapted to their needs, to strengthen their financial.
Show more...Investment focus
- Industry: Health Care, Medical Device, Auctions
- Stage:Series A, Seed
- Geography: Belgium, United States
Investor stats
- Total investments: 8
- Round size: Series A $658k–$18M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Invineo — Invineo design and development of a "smart machine" for catering and hospitality professionals.
- VolitionRx — We are dedicated to revolutionizing the diagnosis and monitoring of life-altering diseases by advancing the science of epigenetics.
- Sunrise — Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate asin-lab sleep studies, at a fraction of the cost.Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.
W.IN.G by Digital Wallonia invests in SAAS, advanced tech and deep tech startups (AI, drones, medtech, IOT,...). W.IN.G brings smart money by helping startups by bi-weekly interactions and providing an operating teams (seasonal entrepreneurs being hands-on with the portfolio).
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Series A, Convertible Note
- Geography: Belgium
Investor stats
- Total investments: 34
- Round size: Seed $346k–$1.9M; Series A $1.1M–$11M; Convertible Note $219k–$555k
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- IONNYK — IONNYK is a new medium of art photography, containing millions of tiny ink capsules.
- MYOCENE — Myocene is a Liège-based sports technology company which creates unique and innovative devices for measuring muscle fatigue and performance.
- Soil Capital Belgium — Discover Europe's first certified, multi-national carbon farming programme that rewards regenerative agriculture.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Our mission is to mature innovation and support the growth of our portfolio companies to create value for patients, society, local ecosystems, and investors.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Series A, Seed
- Geography: Belgium, Japan, France
Investor stats
- Total investments: 22
- Round size: Seed $2.7M–$3.2M; Series A $6.1M–$84M
- Lead/follow: 68% lead, 32% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Bioxodes — Bioxodes is a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics to prevent thrombotic events without hemorrhagic risk.
- Tensegrity Pharma — Tensegrity Pharma is the developer of a novel drug designed to minimize bottlenecks and provide innovative value to patients.
- Augustine Therapeutics — Augustine Therapeutics is developing selective, safe and efficacious HDAC6 inhibitors designed for treatment of neuromuscular, neurodegenerative and cardiometabolic diseases. Discover our pipeline poised for clinical impact.
Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Seed, Series B
- Geography: France, Switzerland, Spain
Investor stats
- Total investments: 142
- Round size: Seed $2.7M–$14M; Series A $3.8M–$98M; Series B $12M–$72M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- EvlaBio — EvlaBio is a biotech company focused on the development of drug programs that address significant unmet medical needs. The company's pipeline includes robust scientific antibody programs for the treatment of hepatocellular carcinoma (Phase 1 ready) and chronic kidney disease with left ventricular hypertrophy (pre-clinical).
- Tacalyx — Tacalyx develops therapeutics targeting cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors where no satisfactory treatments exist.The name Tacalyx is derived from TACA (Tumor Associated Carbohydrate Antigen) and ‘lyx’ from the term Glycocalyx, the glycan-containing layer covering cells. Cancer cells differ fromnormal cells by displaying aberrant carbohydrate structures on their surfaces promoting metastasis, angiogenesis or suppression of the immune system. TACAs result from the aberrant glycosylation that is seen with transformation to a tumor cell and represent attractive targets for cancer treatment since they are displayed with high cancer specificity and enhance tumor virulence via the mentioned diverse mechanisms.
- AM Pharma — AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derivedpeptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
Sensinnovat
Show more...Investment focus
- Industry: Health Care, Manufacturing, Medical Device
- Stage:Seed, Series A, Series B
- Geography: Belgium, France
Investor stats
- Total investments: 5
- Round size: Seed $5.2M–$7.3M; Series A $7.7M–$17M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Hummink — Dream Smaller Now : Experience a revolution with Hummink's world's smallest fountain pen. Redefine micro-scale writing with our innovative technology.
- Azalea Vision — Azalea Vision is a medical manufacturer designing contact lenses with an active light management system for people with ocular disorders.
- Indigo Diabetes — Indigo Diabetes nv (Indigo) is a young high-tech medical device company founded by Danaë Delbeke and her team ended in 2016. Indigo develops the world’s first invisible sensor for people living with diabetes to address their need for accurate glucose monitoring with improved user experience. Indigo exploits groundbreaking photonics technology thatrevolutionized the Internet during the last decades and now aims at transforming diabetes management.
The Amazon Alexa Fund is Amazon’s venture capital fund investing in artificial intelligence, frontier tech, voice, robotics, and digital health across consumer and enterprise. We invest in early- to growth-stage companies globally. To learn more, visit us at alexafund.com.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Machine Learning
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 141
- Round size: Seed $120k–$5.7M; Series A $5.1M–$46M; Series B $11M–$120M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — raised $100M in 2017
Portfolio highlights
- Endel — Personalized soundscapes to help you focus, relax, and sleep. Backed by neuroscience.
- Hearvana — Hearvana is a IT consulting company.
- Fable Studio — Fable is building next-generation AI authoring tools to create interactive characters who can live, learn and make decisions with us.
We empower high-potential entrepreneurship and democratize venture capital. Discover promising start-ups & SMEs and invest alongside business angels.
Show more...Investment focus
- Industry: Information Technology, E-Commerce, Health Care
- Stage:Series A, Seed, Pre-Seed
- Geography: Belgium, France
Investor stats
- Total investments: 16
- Round size: Seed $165k–$1.3M; Pre-Seed $150k–$197k; Series A $247k–$2.5M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Jelloow — Jelloow your virtual marketing navigator. Matching brands with likeminded marketing agencies.
- PlayTreks — Supercharge your music business with PlayTreks, the all-in-one workspace for music professionals. Built for indie artists, artist managers and label teams.
- NietsCo — NietsCo. is the home of Botaniets Gin 0.0%, a leading selection of alcohol-free products, carefully distributed to the world's best restaurants, concept stores, shops and consumers.
Sambrinvest is an active venture capital player in the region of Charleroi - Thuin.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A, Series B
- Geography: Belgium, France, Spain
Investor stats
- Total investments: 40
- Round size: Seed $544k–$24M; Series A $987k–$46M; Series B $4.4M–$45M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Brenus Pharma — Brenus Pharma is an allogeneic platform to generate immune therapy ambitioning to harness patient immune system & prevent cancer resistance over treatment.
- Vertical Compute — Vertical Compute offers chiplet-based technology that cuts data movement to achieve up to 80% energy savings.
- Enodia Therapeutics — Enodia Therapeutics pioneers targeted protein degradation at the Sec61 translocon, developing small-molecule therapies for inflammatory and autoimmune diseases.
TheClubDeal is an investment holding and fund manager co-investing into SME’s and real estate projects. It provides facilitation of governance between non-executive shareholders and entrepreneurs. Its governance structure, including its charter of avoidance of conflict of interests, is therefore paramount to the adequate management of the Company.At TheClubDeal, we connect Investors and Entrepreneurs around promising investment opportunities. For each of these, we will invest ourselves and co-invest with a selected number of investors. We add value by processing strong applied governance principles, when selecting and managing our investments, and by gathering the necessary skills to successfully grow the businesses and real-estate projects we co-invest in. TheClubDeal is launching their second fund, a 50M € PRIVAK/PRICAF in H1 2021 with the mandate to invest in Belgian scale-ups in three sectors: Smart Living, Tech and Life Sciences.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical Device
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: Belgium, France
Investor stats
- Total investments: 18
- Round size: Series A $2.1M–$7.7M; Series B $13M–$18M; Venture - Series Unknown $5.5M–$6.5M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Vaxinano — Vaxinano is a biotechnology company specialized in preclinical and pharmaceutical development of human and veterinary vaccines and drug delivery systems. Vaxinano was created in 2016, building on 25 years of research and clinical trials on vaccines and the patented technology of Pr Didier Betbeder.
- Inpulse — Inpulse is an automated supply management platform for restaurateurs.
- Clouds of care — Increasing your probability of success through the adoption of meaningful endpoints, starting from electrophysiology.
Since 1967, the UI brand embodies a partnership with companies. Actor of the economy, UI has accompanied more than 120 SMEs over the last fifteen years, investing more than 550m € and giving substance to their development projects. Combining experience and corporate culture, UI has established itself as an involved and independent partner, able tocount on its shareholder leaders to favor, independently, the sustainable performance of the SMEs it accompanies.
Show more...Investment focus
- Industry: Manufacturing, Software, Health Care
- Stage:Private Equity, Seed, Series A
- Geography: France, Spain, Canada
Investor stats
- Total investments: 107
- Round size: Seed $1.5M–$5.8M; Series A $3.2M–$33M; Private Equity $3.2M–$49M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely still investing — raised $37M in 2021
Portfolio highlights
- Eclore — Eclore utilizes origami-inspired designs to produce cylindrical and flat protective bellows, as well as specific protection kits for SCARA robots. These components are constructed from materials resistant to solvents, oils, ultraviolet rays, and high-pressure cleaning while maintaining compliance with international standards. The products functionthrough compression and expansion cycles to safeguard equipment from environmental contaminants and mechanical wear. By reducing the total number of parts and overall bulk, the folding technology creates lightweight protective barriers suitable for various industrial diameters.
- Brenus Pharma — Brenus Pharma is an allogeneic platform to generate immune therapy ambitioning to harness patient immune system & prevent cancer resistance over treatment.
- B Capital Partners — B Capital Partners is a financial services firm offering investment advisory solutions with a focus on infrastructure and clean energy.
Inventures is a European venture capital fund that builds a better world through a portfolio of investments in sustainable businesses.The firm has two funds: Inventures I & Inventures II.Inventures was created to support early stage smart and innovative European businesses, to support sustainable job growth and empower entrepreneurs.Inventures empowers citizenship co-investments through a crowdfunding platform, MyMicroInvest.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Manufacturing
- Stage:Series A, Seed
- Geography: Belgium, France, United Kingdom
Investor stats
- Total investments: 46
- Round size: Seed $82k–$2.1M; Series A $411k–$14M
- Lead/follow: 9% lead, 91% follow
- Last fund: May invest from a new fund soon — last raise in 2016
Portfolio highlights
- BiOceanOr — BiOceanOr harnessed the power of Marine Biology and AI to deliver bio-guided services that optimize fish welfare and fish growth, while supporting aquaculture sustainability standards
- myskillcamp — Myskillcamp is a digital learning platform and educational design support service. Myskillcamp supports their customers in the digital transformation of their company and the launch of their Digital Learning project. From the audit of needs to the design of engaging educational devices, through a pilot phase, they make a point of honor to adapt thedigital to the specificities of each and give it meaning.With their online platform, businesses can manage their learner communities and connect all their partners in one place. Their tool also allows businesses to structure training spaces by skills, trades, brands within camps. In parallel, businesses can create educational content from scratch, select a map in their marketplace, or plan sessions in-class. Businesses can organize the distribution of their training to a single learner or to a whole group.
- Octave — Optimize energy use with Octave's battery storage (BESS) and energy management system (EMS). Reduce costs, increase flexibility.
Pierre-Yves Muller is based out of Geneva, Geneve, and is the CTO of MYOCENE. Pierre-Yves previously worked at CEFALY Technology as a CTO. Pierre-Yves Muller attended the Federal Polytechnic School of Lausanne.
Show more...Investment focus
- Industry: Sports, Medical Device
- Stage:Seed, Pre-Seed
- Geography: Belgium
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MYOCENE — Myocene is a Liège-based sports technology company which creates unique and innovative devices for measuring muscle fatigue and performance.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!GoBeyond is a FinTech company transforming angel investing into a new scalable asset class for small and large, novice to experienced investors. It offers a unique deal platform, portfolio tools, syndication/pooling, due diligence, investment monitoring services, training and certified deal leaders.Its clients are individuals, familyoffices, professional groups and corporations. It is active in the EU, Switzerland and the US. GoBeyond also offers educational training modules for angel investors in 11 categories.
Show more...Investment focus
- Industry: Information Technology, Medical, Software
- Stage:Seed, Series A
- Geography: Switzerland, Germany, United Kingdom
Investor stats
- Total investments: 164
- Round size: Seed $544k–$5M; Series A $1.2M–$10M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Stylect — Stylect is a mobile app to to help women discover their perfect shoe. They aggregate products from multiple websites and based on users' preferences (that they gather through a hot-or-not interface), they recommend better products. Their users are able to keep track of and buy the products they like and receive notifications whenever a productthey love goes on sale. Finally, They use geolocation to let their users know when a shoe is selling in a store nearby.
- Prestodiag — Prestodiag develops, manufactures and sells innovative solutions for rapid detection of bacteria. Their analytical solutions are based on an innovative optics technology called Surface Plasmon Resonance imaging and allow detection and identification of pathogenic bacteria such as Salmonella, Listeria or E.coli. They provide users with a result injust a few hours instead of 1 to several days. Their market is primarily the food safety sector, and also on medical and environmental applications.
- Arktis Radiation Detectors — Arktis develops and manufactures next generation systems that detect and categorize radiological and nuclear materials to enhance security and operations.
Expanding nanotechnology into business.
Show more...Investment focus
- Industry: Semiconductor, Manufacturing, Medical Device
- Stage:Seed, Series A, Series B
- Geography: Belgium, United States, Germany
Investor stats
- Total investments: 54
- Round size: Seed $3.3M–$23M; Series A $8.7M–$56M; Series B $12M–$100M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely still investing — raised $351M in 2024
Portfolio highlights
- Invisix — Invisix shrinks the metrology wavelength with soft x-ray light to measure next-gen 3D chips and extend Moore's law for semiconductor makers.
- Eyeo — eyeo revolutionizes imaging with color splitter sensors. Capture sharper, brighter images in low light using optical waveguide innovation, discover how it works
- NEURA Robotics — Cognitive Robotics for Real-World Applications: NEURA Robotics enables safe and smart robot integration for Industry, Work and Everyday Life
Offers health consulting services
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed
- Geography: Belgium, United States
Investor stats
- Total investments: 3
- Round size: Seed $1.1M–$4.5M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- moveUP — Ontvang medische zorg op afstand voor en na uw operatie. moveUP is gespecialiseerd in de begeleiding van knie- en heupoperaties.
- Helpper — Helpper verbindt mensen die thuishulp zoeken voor dagelijkse taken, met hulpvaardige buurtbewoners die een centje willen bijverdienen.
- Neuroventis — Neuroventis emboldening people with neurological disorders. Learn how our technology is changing the world of neurological care.
CAREvolution is a venture capital firm that invests in healthcare sectors.
Show more...Investment focus
- Industry: Health Care, Medical Device, GovTech
- Stage:Seed, Venture - Series Unknown
- Geography: Belgium
Investor stats
- Total investments: 3
- Round size: Seed $1.2M–$4.5M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Hoplr — Hoplr activates the social capital in your neighbourhood such as material, knowledge, time and infrastructure. Hoplr is a digital participation platform for inclusion, citizen participation and neighbourhood care.
- moveUP — Ontvang medische zorg op afstand voor en na uw operatie. moveUP is gespecialiseerd in de begeleiding van knie- en heupoperaties.
- Neuroventis — Neuroventis emboldening people with neurological disorders. Learn how our technology is changing the world of neurological care.
Spinventure supports the creation of spin-off companies that aim to industrialize and commercialize the result of scientific research. Spinventure was born from a collaboration between MEUSINVEST and the University of Liège. It is headquartered in Angleur, Belgium.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A
- Geography: Belgium
Investor stats
- Total investments: 6
- Round size: Series A $768k–$15M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Dim3 — Improve patients outcome - Deliver actionable insights - Save healthcare costs
- Elysia — Elysia developed solution dedicated to quality control laboratories for the production of Radio Pharmaceuticals.
- Convert Pharmaceuticals — Convert Pharmaceuticals develops prodrugs that are inert upon administration to patients, but transform into potent anti-cancer agents upon entering tumors.
Yves Beudin
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Angel
- Geography: Belgium
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- OneLIFE — Enzymatic cleaning solutions against soiling and biofilms for medical devices and the hospital environment. Safe for staff, patients and visitors.
SHIGERU AG is a technology company that leverages technological innovation to enable a new way of life.
Show more...Investment focus
- Industry: Blockchain, Cloud Computing, Virtual Reality
- Stage:Pre-Seed, Seed, Series A
- Geography: United States, Japan, Belgium
Investor stats
- Total investments: 5
- Round size: Pre-Seed $1M–$3M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- DR. PECKER INC. — DR. PECKER is AI & generative AI driven, smart clinics & health tech software solutions, platform and services provider. The industries the company tackles are augmented & immersive user experience in smart clinics & heath tech, medical research, humanity with Meta Verse & Multi Verse extensions.
- RAI — RAI is a mixed reality, generative AI, metaverse, and multiverse software solutions, platforms, and services provider. The industries the company tackles are augmented workspaces, heath tech, media and streaming, humanity, XR/MR + AI, and Meta Verse
- Thunderbirds — Fintech | XR/MR + AI | Metaverse & Multiverse
New Rhein is a Philadelphia based healthcare venture capital firm focused on repurposed assets.
Show more...Investment focus
- Industry: Medical, Biotechnology, Health Care
- Stage:Series A, Series B, Series C
- Geography: United States, Israel, Belgium
Investor stats
- Total investments: 11
- Round size: Series A $12M–$197M; Series B $7M–$23M; Series C $21M–$45M
- Lead/follow: 64% lead, 36% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Corsair Pharma — Corsair Pharma is developing transformative solutions to improve the therapeutic profile of medications and provide superior treatment options for patients.
- Butterfly Medical — Butterfly, Butterfly Medical, BPH Treatment, BPH Office Procedure, Idan Geva, Minimally Invasive BPH, Prostate, Enlarged Prostate, Bening Prostate Hyperplasia, Urology
- Alveus Therapeutics — At Alveus Therapeutics, we are building a differentiated therapeutic portfolio that delivers sustainable weight loss with superior tolerability.
Manuardeo is an early stage investments focused VC firm.
Show more...Investment focus
- Industry: Medical, Diabetes, Health Care
- Stage:Series A, Series B
- Geography: Belgium
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Indigo Diabetes — Indigo Diabetes nv (Indigo) is a young high-tech medical device company founded by Danaë Delbeke and her team ended in 2016. Indigo develops the world’s first invisible sensor for people living with diabetes to address their need for accurate glucose monitoring with improved user experience. Indigo exploits groundbreaking photonics technology thatrevolutionized the Internet during the last decades and now aims at transforming diabetes management.
Jean Dessain - Non Executive Director @ OneLIFE
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Angel
- Geography: Belgium
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- OneLIFE — Enzymatic cleaning solutions against soiling and biofilms for medical devices and the hospital environment. Safe for staff, patients and visitors.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!SoFi is a finance company that offers a range of lending and wealth management services. The company primarily caters to early-stage professionals and offers variable and fixed rate parent, personal, and MBA loans, mortgage refinancing, and more. They create modern financial products and services that help people borrow, save, spend, invest, andprotect their money better so that they can achieve financial independence and realize their ambitions from owning a home to saving for retirement, paying off their student loans, and more.It was founded in 2016 and is headquartered in San Francisco, California.
Show more...Investment focus
- Industry: Software, FinTech, Apps
- Stage:Series A, Seed
- Geography: Belgium, United States, Brazil
Investor stats
- Total investments: 15
- Round size: Seed $500k–$8.5M; Series A $932k–$25M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- zerohash — zerohash provides API-first technology and turnkey regulatory infrastructure to launch and scale compliant crypto and stablecoin products quickly and securely.
- Casap — Casap is an award-winning dispute automation platform that streamlines compliance, reduces operational costs, and enhances consumer satisfaction by automating up to 30% of dispute cases. Trusted by fintechs and financial institutions to deliver fast, accurate, and compliant resolutions.
- Digital Asset — As leaders in blockchain technology, Digital Asset empowers customers with Daml, the leading platform for multi-party applications; an innovative smart contract language and Canton, our privacy-enabled distributed ledger technology.
IMBC is particularly active in the agri-food, technology, and environmental sectors, with direct links to the ecosystems of the Mons Borinage region.
Show more...Investment focus
- Industry: Agriculture, AgTech, Farming
- Stage:Seed, Pre-Seed
- Geography: Belgium
Investor stats
- Total investments: 7
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Fyteko — For a more sustainable agriculture
- BiocSol — BiocSol focus on sustainable microbial-based crop protection.
- Sunrise — Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate asin-lab sleep studies, at a fraction of the cost.Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.
Invest BW is a funding program.
Show more...Investment focus
- Industry: Health Care, AgTech, Medical
- Stage:Series A, Seed, Grant
- Geography: Belgium, Germany
Investor stats
- Total investments: 6
- Round size: Series A $1.1M–$18M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- VCG.AI — Navigate Value at Scale One platform to discover, design, validate, and scale renewable material value chains with deep data and cognitive AI, capturing growth at every step. BOOK A DEMO CALL The Challenge While renewable and circular material strategies offer significant opportunities, they require major investment and introduce new supply chain risks. Fragmented data, complex
- IONNYK — IONNYK is a new medium of art photography, containing millions of tiny ink capsules.
- Minagro — Minagro develops high-quality green products for crop care. Minagro conducts research activities in confirmed proprietary technologies from green and specialty chemistries.
Pierre Drion - CEO @ Petercam
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Series A, Series B
- Geography: Belgium
Investor stats
- Total investments: 5
- Round size: Series A $8.8M–$14M; Series B $18M–$26M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- A-Mansia Biotech — A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering theintestinal epithelium, which allows the bacterium to establish a close cross-talk with the host.
- Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
- Santero Therapeutics — This is the homepage of the website
Flanders Future Techfund operates as an investment firm.
Show more...Investment focus
- Industry: Medical, Biotechnology, Clinical Trials
- Stage:Seed, Series A
- Geography: Belgium, The Netherlands
Investor stats
- Total investments: 7
- Round size: Seed $2.7M–$33M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- EDGX — EDGX, founded in 2023 in Ghent, is a Belgian Space Tech company developing high-speed edge computing units for satellites. Its NVIDIA-powered Sterna Computer and SpaceFeather software enable real-time, AI-driven on-orbit data processing for applications in communication, Earth observation, and intelligence.
- Flindr Therapeutics — Immagene develops personalized cancer immunotherapies to fight multiple cancer type.
- Clouds of care — Increasing your probability of success through the adoption of meaningful endpoints, starting from electrophysiology.
Fidimec is a Belgium-based venture capital firm that offers investment and incubation services for seed stage startups.
Show more...Investment focus
- Industry: Industrial, Semiconductor, Medical
- Stage:Seed, Series A
- Geography: Belgium
Investor stats
- Total investments: 7
- Round size: Seed $2.7M–$4.9M; Series A $2.2M–$7.7M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Aloxy — Aloxy offers reliable IIot solutions tailored to the needs of the process industry. Our valve sensor provides an open and close indication of manual valves.
- Sentea — Sentea makes fibre optic Sensing affordable to the industry and enables continuous monitoring even in harsh environments.
- MICLEDI Microdisplays — MICLEDI Microdisplays is an experienced executive in the semiconductor industry,
We deploy early stage capital to fuel the growth of need-driven health technology companies.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 95
- Round size: Seed $2M–$6.3M; Pre-Seed $529k–$2.4M; Series A $5M–$21M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Biobase — Biobase is the agentic system for clinical data, closing the gap between clinical data and outcomes.
- Ladder Health — Ladder Health offers virtual pediatric therapy and support for early childhood developmental delays, including speech and physical therapy.
- Woodway Assurance — Woodway Assurance provides EviData, an AI-driven software for automated privacy assurance on de-identified and synthetic datasets.
Karista is an early-stage venture capital firm created in 2001 investing in Health, Digital, Tech, and NewSpace.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Series A, Series B
- Geography: France, United States, Finland
Investor stats
- Total investments: 156
- Round size: Seed $713k–$6.3M; Series A $1.2M–$18M; Series B $2.5M–$33M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Tricares — TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system for minimal invasive treatment of tricuspid valve regurgitation.
- Advestigo — Advestigo S.A., a technology company, provides digital assets protection solutions. It offers theraography technology, which analyses digital content to generate content-based fingerprints; AdvestiCHECK, a software package that allows companies to monitor information technology networks and workstations; and AdvestiGUARD, a software package thatallows companies to monitor communication channels. The company was founded in 2002 and is based in Saint-Cloud, France. As of March 9, 2009, Advestigo S.A. operates as a subsidiary of Hologram Industries SA.
- Physikron — Physikron is a developer of mass spectrometry technologies used to improve the performance of tandem spectrometry. Its technologies offer proteomic analysis and dramatically improves the number of peptides and proteins identified during an LC/MS/MS acquisition that enable researchers to research in an enhanced way.
Parana Management
Show more...Investment focus
- Industry: Medical, Diabetes, Health Care
- Stage:Series A, Series B
- Geography: Belgium
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Indigo Diabetes — Indigo Diabetes nv (Indigo) is a young high-tech medical device company founded by Danaë Delbeke and her team ended in 2016. Indigo develops the world’s first invisible sensor for people living with diabetes to address their need for accurate glucose monitoring with improved user experience. Indigo exploits groundbreaking photonics technology thatrevolutionized the Internet during the last decades and now aims at transforming diabetes management.
Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, The Netherlands, Switzerland
Investor stats
- Total investments: 184
- Round size: Series A $7.3M–$78M; Series B $12M–$110M; Series C $12M–$165M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $266M in 2023
Portfolio highlights
- ActoGeniX — ActoGeniX is a biopharmaceutical company focused on the development and commercialization of a range of biological drugs. ActoGeniX was founded by Bernard Coulie and Mark Vaeck in 2006 and is based in Zwijnaarde, Belgium.
- Neurent Medical — Discover NEUROMARK, a minimally invasive solution for Chronic Rhinitis that targets the posterior nasal nerve to provide lasting symptom relief.
- Rotation Medical — Rotation Medical Inc. manufactures and markets a collagen scaffold for rotational cuff disease in Minnesota. The company was formerly known as Denali Medical Inc. and changed its name to Rotation Medical Inc. in March 2010. Rotation Medical was founded in 2009 and headquartered in Plymouth, Minnesota.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!New Economy Startups Investor & Accelerator
Show more...Investment focus
- Industry: Software, Music, Information Technology
- Stage:Seed, Series A
- Geography: Belgium, France, United States
Investor stats
- Total investments: 46
- Round size: Seed $200k–$2M; Series A $247k–$12M
- Lead/follow: 28% lead, 72% follow
Portfolio highlights
- neuroClues — An easy-to-use eye-tracking environment to help practitioners instantaneously quantify their clinical exam
- Gamevestor — Be more than a player. Invest in expert-selected video game projects and earn a share of their commercial revenues.
- CityLegends — A home for urban sports & culture partners of CityLegends. Making the lines.
Eduardo Ronzano is the Co-Founder and CEO of Kolet. He previously worked at The Bradery as a Pre-Seed Investor. Eduardo Ronzano attended ESCP Business School.
Show more...Investment focus
- Industry: Software, E-Commerce, SaaS
- Stage:Seed, Pre-Seed, Angel
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 88
- Round size: Seed $713k–$5.5M; Angel $500k–$2.5M; Pre-Seed $150k–$2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Kraaft — Kraaft.co is an instant messenger app dedicated to site monitoring for VRD public works trades: roads and various networks. Paris, Île-de-France in 2019.
- Frak Labs — The Recommendation Economy makes influence scalable. Turn word-of-mouth into measurable, rewarded growth.
- Poolside — We are software's leading AI research lab.
Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 104
- Round size: Seed $1.8M–$20M; Series A $3.8M–$34M; Series B $11M–$50M
- Lead/follow: 47% lead, 53% follow
- Last fund: May invest from a new fund soon — raised $250M in 2018
Portfolio highlights
- Tacalyx — Tacalyx develops therapeutics targeting cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors where no satisfactory treatments exist.The name Tacalyx is derived from TACA (Tumor Associated Carbohydrate Antigen) and ‘lyx’ from the term Glycocalyx, the glycan-containing layer covering cells. Cancer cells differ fromnormal cells by displaying aberrant carbohydrate structures on their surfaces promoting metastasis, angiogenesis or suppression of the immune system. TACAs result from the aberrant glycosylation that is seen with transformation to a tumor cell and represent attractive targets for cancer treatment since they are displayed with high cancer specificity and enhance tumor virulence via the mentioned diverse mechanisms.
- smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
- Rinri Therapeutics — Rinri Therapeutics has been founded on pioneering research into auditory stem cells led by Professor Marcelo Rivolta at the University of Sheffield.
Qbic is the result of a lot of thinking, debating and sketching of what a city hotel could be; one that breaks the rules and makes people smile.An astonishing level of change has swept through the world over the last few years. But the hotel experience is no different than it’s ever been: stuffy, over-priced and lacking soul. They’re here tochange all that. they’re curious, imaginative and friendly, and they think there are lots of people just like us seeking a hotel with personality in the middle of the city.They believe in something better than what’s currently out there. A place that celebrates life rather than sucks life out of it. A hotel that’s built on creativity and a belief that you don’t have to accept the conventional. Somewhere that sends you away with fun stories and ideas, and is easy on your pocket.
Show more...Investment focus
- Industry: Health Care, Biotechnology, AgTech
- Stage:Seed, Series B
- Geography: Belgium
Investor stats
- Total investments: 7
- Round size: Seed $3.7M–$11M; Series B $8.2M–$12M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- moveUP — Ontvang medische zorg op afstand voor en na uw operatie. moveUP is gespecialiseerd in de begeleiding van knie- en heupoperaties.
- Axithra — Axithra provides therapeutic medication monitoring and measures beta-lactam antibiotic concentrations in blood.
- Cascador Health — Cascador Health bridges the gap between sources and users of healthcare data. Using curated, validated and anonymized RWD allows healthcare providers and life science industry to gain insights and provide better care.
We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, Switzerland, United Kingdom
Investor stats
- Total investments: 161
- Round size: Series A $16M–$187M; Series B $37M–$162M; Series C $14M–$208M
- Lead/follow: 27% lead, 73% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Attenua — 100% satisfaction guaranteed. Hassle-free shopping. We help you find the right domain name.
- Andrew Alliance — OneLab is laboratory software to design and execute liquid handling protocols. Pipette+ for manual liquid handling pipetting and Andrew+ the pipetting robot
- Chord Therapeutics — Chord Therapeutics is a clinical stage pharmaceutical company developing drugs for patients with rare, life-threatening and severely disabling diseases. We are advancing our lead drug candidate CRD1 under orphan drug designation for the treatment of neuromyelitis optica spectrum disorders (NMOSD) and myasthenia gravis (MG).
Fonds Vives II (University of Louvain, UCL)
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Seed
- Geography: Belgium, United States
Investor stats
- Total investments: 5
- Round size: Series A $9.9M–$14M; Series B $6.6M–$75M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Virovet — Antiviral drugs and thermostable vaccines for livestock
- Sunrise — Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate asin-lab sleep studies, at a fraction of the cost.Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.
- ITeos Therapeutics — iTeos Therapeutics is pioneering the discovery and development of highly differentiated immuno-oncology therapeutics for cancer patients.
Sofinex is an investment comapny.
Show more...Investment focus
- Industry: Wellness, Lifestyle, Health Care
- Stage:Series A
- Geography: Belgium
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Sunrise — Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate asin-lab sleep studies, at a fraction of the cost.Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.
Early stage VC investments and funding for start-ups / founders in Ireland.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 112
- Round size: Seed $795k–$2.6M; Series A $1.6M–$6.6M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely still investing — raised $82M in 2022
Portfolio highlights
- CleverCards — The Platform for Contactless Cards. The CleverGift real-time payment platform offers gift cards, expenses, employee incentives, and travel foreign exchange.
- Bloomberg PolarLake — Streamline the acquisition, management and distribution of instrument, pricing, index, legal and ratings data from multiple delivery channels.
- WhatClinic.com — WhatClinic.com helps patients find, compare and book the right clinics for them, in more than 135 countries. They provide detailed listings for over 120,000 clinics on their site. These include doctors, dentists, beauty and cosmetic surgery, physiotherapy, fertility, holistics and a lot more. They believe that every patient is an empoweredconsumer.
The Federal Holding and Investment Company (SFPI-FPIM) centrally manages the federal government’s shareholdings, cooperates with the government on specific projects and pursues its own investment policy in the interests of the Belgian economy.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series A
- Geography: Belgium, United States, The Netherlands
Investor stats
- Total investments: 41
- Round size: Series A $4.3M–$46M; Series B $11M–$75M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Cohabs — We create sustainable & community-driven shared homes around the world for young workers and interns. Join our community.
- Axelera AI — Axelera AI is a company that delivers purpose-built hardware and software platforms designed to accelerate artificial intelligence tasks, particularly in edge computing. The company's flagship product, the Metis™ AI Platform, integrates both hardware and software components to deliver high-performance, energy-efficient AI inference solutions.This platform has been recognized for its innovation, notably being named a CES® 2024 Innovation Awards Honoree.Incubated in 2019 by the emerging technologies leader Bitfury and joined by the leading nano-technology group imec in early 2020, Axelera AI launched as a new company in 2021. Headquartered in the AI Innovation Center of the High Tech Campus in Eindhoven, Axelera AI has R&D offices in Belgium, Switzerland, and Italy. Its team of experts in AI software and hardware hail from top AI firms and Fortune 500 companies.
- Tangent Works — Create predictive models in seconds for faster and better forecasting & anomaly detection with TIM InstantML.
Founded in 1997, Earlybird is a pan-European VC investor backing tech-enabled companies and investing in their growth and development. Funds include Earlybird, Earlybird Health, Growth Opportunities.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Seed, Series B
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 364
- Round size: Seed $1.5M–$14M; Series A $4.4M–$34M; Series B $6M–$75M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely still investing — raised $190M in 2024
Portfolio highlights
- Hilo — Get stress-free readings round the clock with Hilo's clinically validated blood pressure monitor. Learn more
- TrillerTV — FITE is a direct-to-consumer digital live streaming service for combat sports. The platform is specializing in broadcasting professional wrestling, mixed martial arts and boxing events. FITE streams a rich array of live pay-per-view events, subscription packages and thousands of hours of live and on-demand free programs to millions of fans aroundthe world.FITE's mission is to help fans discover and watch premium live events, and help programmers to distribute and monetize them. While FITE's beachhead market is combat sports, the product is designed to serve over time a much wider range of premium live programming.It was founded in 2016 and is headquartered in Uniondale, New York, United States.
- Neuracore — The robot skill creation engine: collect demonstrations, curate datasets, train imitation and reinforcement learning policies, and deploy them on real robots, all on one platform.
Medical Device Investor funding in Belgium at a glance
Stats across 98 deals from 146 investors.
Access all 146 investors in Belgium Medical Device startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Device Investors in Belgium investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 146 investors investing in Belgium Medical Device startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!